Back
  1. Home
  2. Request Item
institution logo
If you're member of the institution,  you just have to login to download the file in restricted access. It is not necessary to request a print.

Request copy

Avelumab (MSB0010718C ; anti-PD-L1) as a first-line treatment for patients with advanced NSCLC from the JAVELIN Solid Tumor phase 1b trial : safety, clinical activity, and PD-L1 expression
Verschraegen, C.; Chen, F.L.; Spigel, D.R. et al.
2016 • In Journal of Clinical Oncology, 34, p. 9036

Document(s) requested
Avelumab (MSB0010718C ; anti-PD-L1) as a first-line treatment for patients with ... - abstract.pdf

The desired document is not currently available on open access. Nevertheless you can request an offprint through the form below. If your request is accepted you will receive by e-mail a link allowing you access to the document for 5 days, 5 download attempts maximum.


Request form

Fields marked with ✱ are compulsory.

Back to the reference
Contact ORBi